Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
CAUSES
UNILATERAL
Papillitis
Anterior Ischemic optic
neuropathy (AION)
Neuroretinitis
Papillophlebitis
retinal vein
Ischemic CRVO central
occlusion
Anterior compressive optic
neuropathies (orbital
tumors)
Infiltrative optic
neuropathies
Ocular hypotony IOP < 5mmHg
Foster-Kennedy syndrome
BILATERAL
Papilledema
Hypertension
Diabetic papillopathy
Advanced Graves disease
Cavernous sinus
thrombosis
Carotid cavernous fistula
Leber hereditary optic
neuropathy
ETIOLOGY
1. Intracranial space occupying lesion
neoplasm (location of the tumor is more important than size)
abscess/inflammatory mass
hemorrhage/infarct
A-V malformation
2. Obstruction of ventricular system
3. Cerebral edema
4. Impaired CSF absorption by arachnoid villi:
Meningitis
Raised venous pressure
SAH/trauma subarachnoid hemorrhage
Communicating hydrocephalus
5. Severe systemic hypertension
6. Idiopathic (pseudo tumor cerebri):
7. Decreased size of cranial vault:
Craniosynostosis
Thickening of skull
8. Hypersecretion of choroids plexus tumor
CLINICAL FEATURES
SYMPTOMS
Ocular:
Visual acuity-normal in early ,decreased when
established and grossly affected when atrophic
Amaurosis fugax(spasm of arteries) transient monocular blindness
Central vision affected late(selective loss of peripheral
neurons)
Diplopia(assoc. 6th cranial nerve palsy in raised ICT)
intracranial tension
General:
Headache (bifrontal/occipital) more in the morning,
aggravated by coughing straining
Projectile vomiting
Loss of consciousness/ focal neurological deficits
CLINICAL FEATURES
SIGNS
1. PUPILLARY REACTION -normal until optic atrophy sets in
2. FUNDOSCOPY
EARLY PAPILLEDEMA
Hyperemia/elevation of disc
Blurred margins
Loss of SVP spontaneous venous pulsation
Superficial hemorrhage
+ Peripapillary halo
CLINICAL FEATURES
ESTABLISHED/FULLY DEVELOPED PAPILLEDEMA:
CLINICAL FEATURES
CHRONIC/VINTAGE PAPILLEDEMA:
Hyperemia decreases and optic atrophy sets in
CLINICAL FEATURES
ATROPHIC PAPILLEDEMA:
CLINICAL FEATURES
3. FIELD CHANGES
Early-normal
Established-enlargement of blind spot
Chronic-peripheral constriction
End stage-total loss
4. FLUORESCEIN ANGIOGRAPHY
UNILATERAL PAPILLEDEMA
Asymmetric
Foster Kennedy syndrome
Seen in patients with frontal lobe/olfactory lobe
tumors, meningiomas of olfactory
groove/sphenoidal wing, characterized by optic
atrophy on the side of the tumor caused by direct
pressure on the nerve and papilledema on the
opposite side because of raised ICT.
Prior optic atrophy, congenital abnormality in disc,
high myopia
PSEUDOTUMOR CEREBRI
Or Benign Intracranial hypertension
Defined by 4 criteria
1. Increased intracranial pressure
2. Normal or small ventricles
3. No evidence of intracranial mass lesion
4. Normal CSF composition
Usually idiopathic seen in young obese women
ETIOLOGY
Endocrine causes
Addisons disease
Hypoparathyroidism
Hyperthyroidism
Hypothyroidism
Menopause
Menarche
Pregnancy
Drugs
Vitamin A
Tetracycline
Steroids
OCP
Phenytoin anti-epileptic drug
Indomethacin NSAIDS
Growth hormone
lithium
TREATMENT
Weight loss
Acetazolamide carbonic anhydrase inhibitor - to reduce IOP
Lumbar puncture
Surgical decompression (ventriculo-peritomeal shunt)
VP-shunting
- shunt cerebrospinal fluid (CSF) from the
lateral ventricles of the brain into the peritoneum
Papillitis
Papilledema
1.Presentation
U/L
B/L
2.Vision
Sudden loss
Unimpaired initially
3.Pupil
RAPD present
RAPD absent
4.Media
Media clear
5.Pain/tendeness of eyeball
Present
Absent
6.Hemorrhages/exudates
Less
More(in established)
7.Disc swelling
+2 to +3D
>+3D
8.Field defects
central/centrocaecal scotoma
9.X-ray skull
Normal
10.CT/MRI
Demyleinating
ICSOL etc.
intracranial space occupying lesion
Hazy media
3. AION/LHON/TOXIC AMBLYOPIAS
Leber hereditary optic neuropathies
4. OCULAR HYPOTONY
6. CRVO
ETIOPATHOGENESIS
1.
2.
3.
IDIOPATHIC
DEMYELINATING (Always Retrobulbar)
Isolated
a/w multiple sclerosis
neuromyelitis optica
schilders disease
ETIOPATHOGENESIS
ETIOPATHOGENESIS
4.IMMUNE RELATED
LOCAL
Uveitis, sympathetic ophthalmitis.
SYSTEMIC
sarcoidosis, Wegeners polyarteritis nodosa, SLE etc.
5.METABOLIC
Anemia
Diabetes
Starvation
6.DRUGS AND TOXINS
INH, ethambutol, etanercept, INFa, tobacco, alcohol,
quinine.
CINICAL FEATURES
Commonly unilateral, more in females and mean age is 30-35 yrs.
SYMPTOMS
Triad of
Loss of central vision
Eye pain
Decreased colour vision
Other
Altered perception of moving objects
Worsening of symptoms with elevation of body
temperature(uhthoff sign)
CINICAL FEATURES
SIGNS
CINICAL FEATURES
Papillitis
Neuroretinitis
INVESTIGATIONS
To determine cause for optic neuritis
1.Complete Hemogram
2. CRP, ESR, Mantoux
3. VDRL
4. Serology-ANA, Toxoplasma, Lymes
5. PNS X-ray, chest x ray(sarcoidosis)
6. X ray skull, CT
7. MRI(demyleinating plaques-2 or more predictive of
deveplopment of MS)
8. Lumbar puncture-CSF pleocytosis and oligoclonal
bands
TREATMENT
1. ONTT Regimen - Intravenous methylprednisolone 250mg q
6 h for 3 days followed by
Oral prednisolone 1 mg/kg/day for 11 days,
tapered with 20mg on 15th day and 10mg on 16th and 18th
day
2. Posterior sub-tenon injection of triamcinolone
3. Vitamin B12
4. Treatment of identifiable cause
Clinical Features
Features
Arteritic AION
Age
>60yrs
40-60yrs
Sex Ratio
F>M
F=M
Vision loss
Severe
Moderate (>6/60)
Laterality
Optic disc
Assoc. Signs
ESR
>40 mm in 1st hr
20-40mm in 1st hr
FAG
Treatment
IV methylprednisolone
? Levadopa-carbidopa
Prognosis
Poor
THANK YOU